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The complete amino acid sequence of the cysteine proteinase inhibitor from potato tubers was determined. The inhibitor is a single-chain protein 
having 180 amino acid residues. Its primary structure was elucidated by automatic degradation of the intact protein and sequence analysis of 
peptides generated by CNBr, trypsin and glycyl endopeptidase. A search through the protein sequence database showed homology to other plant 
proteinase inhibitors of different specificities and non-inhibitory proteins of M, around 20,000. On the basis of sequence homology, prediction of 
secondary structure and fold compatibility, based on a 3DlD score to the threedimensional profile of Erythrina caffra trypsin inhibitor, we suggest 
that the potato cysteine proteinase inhibitor belongs to the superfamily of proteins that have the same pattern of three-dimensional structure as 
soybean trypsin inhibitor. This superfamily would therefore include proteins that inhibit three different classes of proteinases - serine, cysteine and 
aspartic proteinases. 
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1. INTRODUCTION 
Protein inhibitors of cysteine proteinases (CPIs), with 
M,s from 10,000 to 13,000, have been isolated from 
various human and animal tissues [1,2], as well as from 
plants [3,4]. Their characterization revealed that they 
are structurally related proteins, forming the cystatin 
superfamily. The general mode of action of this group 
of inhibitors has been proposed on the basis of the 
crystal structure of chicken cystatin and a docking 
model of its interaction with papain [5], and was con- 
hrmed by X-ray structure of human stefin B in complex 
with papain [6]. 
Recently, a group of a new type of CPI was isolated 
from potato tuber (PCPI) [7]. PCPIs are single-chain 
proteins with M,s ranging from 22,000 to 25,000, with 
different isoelectric points (PI) and inhibitory properties 
[7]. N-terminal sequences of some PCPIs have shown 
that they are homologous proteins related to the 
Kunitz-type soybean trypsin inhibitor (STI) [8]. The 
inhibitory specificity of the PCPI 8.3, the structure of 
which is described in this article, towards several human 
and plant proteinases was determined and compared 
with that of chicken egg white cystatin. It was character- 
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ized as a potent inhibitor of lysosomal proteinase 
cathepsin L with a Ki 0.07 nM [9]. 
A protein inhibitor of cathepsin D was also isolated 
from potato and was shown to possess homology to ST1 
[lO-121. Recently, three proteins, of so far unknown 
function, were purified from potato tuber [13]. Their 
N-terminal sequences were homologous to ST1 and 
matched the amino acid sequence deduced from the 
cDNA sequence of an abundant potato tuber protein 
u41* 
In this work the complete primary structure of the 
major form of PCPI with p1 8.3 (PCPI 8.3) is reported 
and compared with the protein structure database. 
2. MATERIALS AND METHODS 
PCPI 8.3 was purified from potato tubers as described previously 
[7]. Sequentially pure inhibitor was reduced with /I-mercaptoethanol 
and afterwards S-alkylated in two different ways with iodoacetic acid 
(Sigma, USA) and 4-vinylpyridine (Fluka, Switzerland) [151. 
CNBr cleavage of alkylated PCPI 8.3 was made in 85% trifluoroace- 
tic acid, with a 50-fold molar excess of the reagent (Pierce., USA), 
under reducing conditions. The reaction, which took place in the dark 
at room temperature for 24 h was quenched with a lo-fold dilution 
of the reaction mixture with distilled water and freeze dried. 
Hydrolysis by /3-trypsin (EC 3.4.21.1) was made on carboxymethyl- 
PCPI 8.3 (CM-PCPI 8.3) and on maleylated, pyridylethylated-PCPI 
8.3 (PE-PCPI 8.3). Maleylation, as well as demaleylation, was accom- 
plished according to the procedure of Butler and Hartley [16]. The 
cleavage conditions in both cases were 0.1 M N-methyhnorpholinel 
acetate buffer, pH 8.00, 38°C and 2-h incubation with 2.5% (w/w) 
/I-trypsin [17]. 
Glycine-specific papaya proteinase IV (PP IV) (glycyl endopepti- 
dase; EC 3.4.22.25) [18] cleavage of PE-PCPI 8.3 was performed in 0.1 
M sodium phosphate buffer, pH 6.52, containing 1 mM EDTA and 
2 mM dithiothreitol. The reaction was carried out at room tempera- 
ture for 20 h with 2% (w/w) proteinase. 
Peptide mixtures were separated by HPLC (Milton Roy, USA) on 
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Chrompack reverse-phase C8 and C,, columns (100 x 3 mm) equili- 
brated with 0.1% trifluoroacetic acid in water and eluted by various 
linear gradients of 80% acetonitrile containing 0.1% trifluoroacetic 
acid. The flow rate was 1 mUmin. Also gel filt~tion chromatography 
on Sephacryl S-200 HR (Pharmacia, Sweden) was used for peptide 
purification. Column (150 x 0.5 cm) was eluted with 50% HCOOH at 
a flow rate 2.4 ml/h. Absorbance was monitored at 215 and 280 nm, 
respectively. 
Amino acid analyses of peptide hydrolysates, obtained after 24-h 
hydrolysis in 6 M HCl at 1 10°C were performed by HPLC (Milton 
Roy, USA), using an ODS 2 column and pre~olumn ~-phthalalde- 
hyde derivatization. 
Applied Biosystems (USA) liquid-pulsed protein sequencer 475A, 
on-line connected to phenylthiohydantoin amino acid analyser 120A 
from the same manufacturer, was used for the amino acid sequence 
determination. 
A search through the PIR (Protein Identification Resource), release 
33 protein database of protein sequences was performed by the pro- 
gram SEARCH [19]. A database search employing the 30 profile was 
done using the set of programs of Bowie et al. [20]. The protein 
alignment was supported by running the package for multiple se- 
quence alignment ClustalV [21]. Secondary structure was predicted 
according to the method of Robson and Gamier [22]. Alignment was 
presented using programs Maligned [23] and Boxshade (program by 
Kay ~ofmann). Tertiary structures of ~r~~~~~~u caffra trypsin inhibi- 
tor (ITIE) and human interleukin 1 /l (1IlB) were obtained from the 
Brookhaven Protein structure database [24,25]. 
3. RESULTS AND DISCUSSION 
The native PCPI 8.3 was subjected to N-terminal 
amino acid sequence analysis. A single sequence was 
obtained up to amino acid residue 41 (uncleaved mole- 
cule in Fig. 1). 
PCPI 8.3 was reduced with B-mercaptoethanol and 
alkylated with either iodoacetic acid or 4-vinylpy~dine. 
PE-PCPI 8.3 was cleaved with CNBr and the cleavage 
products separated by gel-filtration chromatography. 
50% HCOOH was used as eluent. The resulting four 
peptides were sequenced (CNl-CN4 in Fig. 1). In the 
case of CN3 the first two amino acid residues could not 
be identified, after the third residue the sequence was 
clear up to Lys’13. The yields of CN2 and CN3 were 
normal (more than 50%) in spite of the unfavourable 
Met”-Se?’ and Met7’-Thr8’ peptide bonds which pre- 
ceded them. 
The second set of peptides was prepared by trypsin 
cleavage of CM- and PE-PCPI 8.3 (T peptides in Fig. 
1). As the alkylated molecule, in both cases, was only 
barely soluble in the digestion buffer, the precipitated 
protein was thoroughly suspended by sonication before 
the addition of the proteinase. Peptides in the soluble 
fraction of the digest were sequenced. T3 peptide pro- 
vided the overlap between peptides CNl and CN2. Pep- 
tides TIO, T16 and T17 + 18 revealed new parts of the 
PCPI 8.3 structure. Peptide T17 + 18 represented the 
C-terminus of PCPI 8.3, as the C-terminal Ala residue 
would not have been a site of cleavage by /3-trypsin. 
In order to increase the solubility of the unfolded 
PCPI 8.3, PE-PCPI 8.3 was maleylated. Indeed, maleyl- 
ated protein dissolved readily in the tryptic cleavage 
16 
buffer. Following fragmentation by /I-trypsin and sepa- 
ration, peptides were demaleylated and subjected to 
amino acid sequence analysis (R peptides in Fig. 1). 
Peptide R5 gave the structure of the very hydrophobic 
core of the inhibitor. It provided the overlap between 
peptides CN2 and CN3 and positioned the peptide TlO. 
R6 peptide confirmed the structure of the C-terminus of 
PCPI 8.3. 
The last set of PCPI 8.3 peptides was obtained with 
glycyl endopeptidase (PP peptides in Fig. 1). The pep- 
tide from the central part of the molecule was not found 
in the soluble part of the reaction mixture. The last 
overlaps were provided with the peptides PPIO (between 
TlO, T12 and CN4) and PP13 + 14 (between T16 and 
T17 + 18) which also represented the C-terminal PP 
peptide. 
PCPI 8.3 is a single-chain protein, comprising 180 
amino acid residues. Its calculated M, is 20,085 (assum- 
ing 2 disulphide bonds). 
The primary structure of PCPI 8.3 differs only in one 
amino acid residue from the published cDNA sequence 
encoding a 22-kDa potato tuber protein (Gly replacing 
Arg in position 132, Fig. l), which was thought to be 
a putative inhibitor of the serine proteinases [14]. This 
and previous work [93, however, established that PCPI 
8.3 is an inhibitor of the cysteine proteinases. In addi- 
tion it was also known that PCPI 8.3 does not inhibit 
trypsin and chymotrypsin [8]. 
A search through the protein sequence database 
pointed to a homology to proteins related to Kunitz 
type trypsin inhibitors. Homology of about 20% was 
found with trypsin inhibitors of the soybean trypsin 
inhibitor family 1261, aspartic proteinase inhibitors from 
potato [27,10] and non-inhibitory proteins miraculin 
(MRC) [28] and plant albumin [29]. Up to now, the 
tertiary structures of three proteins of this superfamily 
have been determined - ST1 [30], Erythrina caffra tryp- 
sin inhibitor (ETI) 1311 and wheat ~-amylase/proteinase 
K (subtilisin) inhibitor (WASI) 1321. Prediction of sec- 
ondary structure has shown that PCPI 8.3 is predomi- 
nantly a p-type protein having 58% of B-structure, 
which is in accordance with the percentage of p-struc- 
ture deduced from the tertiary structures of STI, ET1 
and WASI (Fig. 2). 
Since the primary structure revealed homology in the 
‘twilight zone’ we employed a three-dimensional profile 
search to identify possible three-dimensional homology. 
A search through the database was performed using the 
3D profile of ETI. A profile was constructed from the 
tertiary structure by classifying each residue into one of 
18 classes, depending on its accessibility to the solvent, 
polarity of its surroundings and secondary structure 
[20]. A search through the primary structure database 
using such a 3D-1D profile has a high probability of 
identifying protein sequences that can fold into the same 
three-dimensional structure, i.e. which are compatible 
with the same structural framework. The Z score of 
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1 1Q 20 30 40 50 50 
I;vLpEw~~~LRIOERYIINNpLtoAoAwLyNI~NyzCPNAvLQHEdSIPQ~EOT 
uncleaved molecule 
LVLPEVYDQDGNPLRIGERYIINNPLLGAGAVYLYNIGNLQ... 
CN1 CN2 
L~PE~DQ~GNPLRIGERYI~NNPLLGAGA~LYNIGNL... SIPQFLGEGT 
Tl T3 
LVLPEVYDQDGNPLR YIINNPLLGAGAVYLYNIGNLQCPNAVLQHMSIPQFLG 
Rl R3 
LVLPEVYDQDGNPLR R2 YIINNPLLGAGAVYLYN... 
IGER 
PPl+2 PP5 PP7+8 
LVLPEVYDQDGNPLRIG PP3 AVYLYNIG PP6 EGT 
ERYIINNPLLG NLQCPNAVLQHMSIPQFLG 
70 80 90 100 110 120 
PWFVRKSESDYGDVVRVMTWYIKFFVKTTKL ~EQLWTGGKVGNENDI 
CN2 CN3 
PW~SESDYGD~V XX~IKFF~TT~~QT~~DEQL~GGK... 
TlO 
VGNENDI 
R4 
KSESDYGDWR R5 
~~IKF~TT~~DQT~~DEQL~GXVGN... 
PP7+8 PPlO 
PWFVRKSESDYG NENDI 
130 140 150 160 170 180 
FKIMKTDLV!l?PGGSKYVYKLLKCPSKLGCKNIt3GNFKNGYPRLV!J!VDDDKDFIPFVFXKA 
CN4 
KTDLVTP~SKY~~LHCPSHLGC~I~NF~GY... 
T10 T12 T15 T17+18 
FK TDLVTPGGSK T13 NIGGNFK T16 LVTVDDDKDFIPFVFIKA 
YVYK NGYPR 
R6 
LVT~DD~FIPFVFI~ 
PPlO PP12 
FKIMKTDLVTPG PPll CKNIG PP13+14 
GSKYVYKLLHCPSHLG GNFKNGYPRLVTVDDDKDFIPFVFIKA 
AlaA 4 Gln Q 6 Leu L 16 Ser S 5 
ArgR 5 Glu E 6 Lys K 14 ThrT 9 
AsnN 12 Gly G 17 MetM 3 TrpW 1 
AspD 12 His H 3 Phe F 9 Tyr Y 9 
Cys c 4 Ile I 11 Pro P 10 Val V 24 
Total: 180 residues, Mr 20085 
Fig. 1. The amino acid sequence and composition of PCPI 8.3 and the strategy of its determination. Peptides designated as CN were obtained with 
CNBr cleavage. T and R peptides resulted from tryptic fragmentation of PCPI 8.3 and maleylated PCPI 8.3, respectively. PP peptides are from 
glycyl endopeptidase (PP IV) hydrolysis of the inhibitor molecule. The residues which were not directly identified are marked (X). 
PCPI 8.3, based on the 3D-1D profile of 1TIE was 6.84. 
It was resolved together with a group of trypsin inhib- 
itors (2 scores 51 l), aspartic proteinase inhibitors 
from potato (Z scores 4.658) and some other, homol- 
ogous, non-inhibitory proteins, as MRC or plant albu- 
min, from the rest of proteins in the database. 
It was found out earlier that the structure of inter- 
let&in-la- and fi, as well as fibroblast growth factor, 
have the same fold as STI, despite the lack of any detect- 
able sequence homology [3 1,331. A scan of the database 
with the 3D-1D profile of interleukin 18 assigned to 
PCPI 8.3 a Z score of 4.5, and 4.1-4.6 to aspartic pro- 
17 
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PCPI LVLPE.VYDQDGNPLRIGERYIINNPLLGA..GAVYLYNIGNLQCPNAVLQ~SIPQFLGEGT 
pred.SS ----- __>>>****_____-___--**__ . ..-------- >>_-->_~~~__--_____c>** 
3D ET1 ***>>>>***>>>>______*~~.~~~~*____*~~~~*~**____~*~.~~~****- 
PCPI FKIMKTDLVTPGGSKYVYKLLHCPSHL.GCKNIGG..NFKNGYPRLVTVDDDKDFIP~FI~ 
pred.SS ~~~~_____-*>>*_-__-_--__>>>~>-_---> ..>>>>**-------X>XXX-XxXxXxX 
3D ET1 >>**___-__->>>>.-___-__*>>>>*----____>>>~~*--_--~~*~~*_---_~-***~ 
Fig. 2. Comparison of predicted secondary structure of PCPI (pred. SS) with aligned secondary structure lements deduced from tertiary structure 
of ETI. Symbols used in the semi-graphical representation: helical conformation, X; extended, -; turn, > ; coil, *; insertion in the sequence, ‘.
teinase inhibitors from potato, thereby further support- 
ing the hypothesis of a structural relationship between 
PCPI 8.3 and the Kunitz type trypsin inhibitors. 
Alignment of protein sequences (Fig. 3) was pro- 
duced by aligning the structures of PCPI 8.3, NID 
(novel inhibitor of cathepsin D) and MRC against the 
sequence profile based on tertiary structure alignment 
of three inhibitors with known crystal structure, accord- 
ing to the algorithm of Gribskov et al. [34], as imple- 
mented by the program ClustalV [21]. Manual interven- 
tion was applied to include information from the sec- 
ondary structure prediction in the sequence alignment. 
The homology of alignment of PCPI with STI, ETI, 
WASI, NID from potato and MRC was 23, 20, 23, 21 
and 22%, respectively. 
On the basis of sequence homology, prediction of 
secondary structure and fold compatibility based on a 
3D-1D score of the three-dimensional profile of ETI, 
PCPI 
ST1 
ET1 
WAS1 
NID 
MRC 
PCPI 
ST1 
ET1 
WAS1 
NID 
MRC 
PCPI 
ST1 
ET1 
WAS1 
NID 
MRC 
PCPI 
ST1 
ET1 
WAS1 
NID 
MRC 
* 
;, 
L 
R 
: 
. . . . . . . 
. . . . . . . . . . 
L 
Fig. 3. Alignment of the primary structures of PCPI 8.3, soybean trypsin inhibitor (STI), Erythrina cuffra trypsin inhibitor (ETI), wheat 
a-amylaselsubtilisin hibitor (WASI), novel inhibitor of cathepsin D (NID) and miraculin (MRC). The Pl position of the scissile bond of STI, 
ET1 and WAS1 is marked by *. 
18 
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we suggest that PCPI 8.3 belongs to the su~rfamily of 
proteins that have the same pattern of three-dimen- 
sional structure as STI. 
The superfamily of ST1 would thus comprise proteins 
which have inhibitory activity against serine proteinases 
(trypsin and subtilisin family), aspartic proteinases (in- 
hibitors active against cathepsin D), cysteine pro- 
teinases (inhibitors to papain family) and proteins with 
some other activity or function, like MRC with its sweet 
taste-modifying activity, or plant albumin, presumably 
functioning as a storage protein. Some of the members 
have multiple activities, like in~bition of serine and 
aspartic proteinases (NID, [IO]) or inhibition of a-amy- 
lase and subtilisin [32]. 
PI 
[31 
[41 
PI 
The active site of PCPI 8.3 against cysteine pro- 
teinases cannot be determined based on the information 
available. According to the alignment, instead of argin- 
ine at the Pl position of the scissiie bond (marked by 
* in Fig. 3) in ST1 and ETI, lysine is positioned in PCPI 
8.3. In the case of WASI this is also the site, located at 
the active site of proteinase K [32]. Conformation of the 
reactive loop in STI-type of trypsin inhibitors is con- 
served by a hydrogen bonding network [31]. Topology 
of the loop in PCPI 8.3 is probably disturbed, due to 
neighboring insertions, which can explain why PCPI 8.3 
does not inhibit serine proteinases. 
[91 
WI 
WI 
f131 
[I41 
There are at least 16 different families of inhibitors of 
the serine proteinases and most of them obey the ‘ca- 
nonical’ mechanism of inhibition 135,361. Inhibition of 
trypsin with ST1 follows this model. In contrast, all of 
the known inhibitors of cysteine proteinases of the pa- 
pain family were grouped into one structurally related 
superfamily of proteins [2]. The mechanism of inhibi- 
tion of cysteine proteinases by cystatins differs from the 
standard model. Cystatins do not bind in a substrate- 
like manner and are not cleaved by the enzyme but 
rather form a non-covalent complex with the enzyme 
through predominantly hydrophobic interactions, 
thereby sterically preventing the access of a substrate to 
the active center [6]. 
WI 
The primary structure of PCPI 8.3 is the first cysteine 
proteinase inhibitor structure not homologous to the 
structure of cystatin. Whether the inhibition of PCPI 8.3 
follows the inhibition mechanism of cystatins, by some 
other parts of the structure substituting for contact re- 
gions found in cystatins, or accomplished by some other 
mechanism, remains to be established. 
WI 
[I71 
WI 
1191 
r-m 
WI 
P21 
1231 
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